GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Capex-to-Operating-Cash-Flow

BIO-key International (BIO-key International) Capex-to-Operating-Cash-Flow : 0.00 (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

BIO-key International's Capital Expenditure for the three months ended in Sep. 2023 was $0.00 Mil. Its Cash Flow from Operations for the three months ended in Sep. 2023 was $-0.17 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


BIO-key International Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for BIO-key International's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-key International Capex-to-Operating-Cash-Flow Chart

BIO-key International Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BIO-key International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BIO-key International's Capex-to-Operating-Cash-Flow

For the Security & Protection Services subindustry, BIO-key International's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-key International's Capex-to-Operating-Cash-Flow Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BIO-key International's Capex-to-Operating-Cash-Flow falls into.



BIO-key International Capex-to-Operating-Cash-Flow Calculation

BIO-key International's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.082) / -6.229
=N/A

BIO-key International's Capex-to-Operating-Cash-Flow for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / -0.167
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-key International  (NAS:BKYI) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


BIO-key International Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BIO-key International's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-key International (BIO-key International) Business Description

Traded in Other Exchanges
N/A
Address
3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Executives
Michael W Depasquale director, officer: Co-Chief Executive Officer 1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan officer: See Remarks 411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams director 400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok director FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia director 15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel director C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd 10 percent owner 5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin director FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis director 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao director SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush, director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch officer: Chief Financial Officer PO BOX 588, DUNSTABLE MA 01827
John Schoenherr director C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803

BIO-key International (BIO-key International) Headlines

From GuruFocus